These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30086678)

  • 21. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as "toxic epidermal necrolysis-like".
    Eldani C; Darrigade AS; Beylot-Barry M; Jullie ML; Ducharme O; Milpied B; Pham-Ledard A
    Eur J Dermatol; 2022 Nov; 32(6):805-807. PubMed ID: 36856394
    [No Abstract]   [Full Text] [Related]  

  • 23. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pembrolizumab-induced Stevens-Johnson Syndrome with Severe Ocular Complications.
    Ryu S; Jun I; Kim TI; Seo KY; Kim EK
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1533-1535. PubMed ID: 33826467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Stevens Johnson - Toxic Epidermal Necrolysis Immunotherapy related Toxicities in Lung Cancer Patients.
    Alexandris D; Alevizopoulos N; Gakiopoulou H; Stavrinou N; Vourlakou C
    J Oncol Pharm Pract; 2022 Jul; 28(5):1276-1282. PubMed ID: 35038934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bullous drug reaction after pembrolizumab administration: two case reports].
    Golle L; Michl C; Kreft B
    Dermatologie (Heidelb); 2022 Dec; 73(12):959-964. PubMed ID: 35925211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenytoin induced Stevens-Johnson Syndrome-toxic Epidermal Necrolysis Overlap Exacerbated by Cephalexin in a 65-Year-old Neurosurgical Patient: A Rare Case Report.
    Rathinam KK; Sabarathinam S; Nuthalapati P; Mahalingam VT
    Curr Drug Res Rev; 2022; 14(1):80-83. PubMed ID: 34225642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
    Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lichenoid dermatitis preceding Stevens-Johnson syndrome in a patient treated with nivolumab.
    Potts J; Lee RR; Hilliard CA
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36028237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stevens-Johnson Syndrome Induced by Pembrolizumab in a Lung Cancer Patient.
    Haratake N; Tagawa T; Hirai F; Toyokawa G; Miyazaki R; Maehara Y
    J Thorac Oncol; 2018 Nov; 13(11):1798-1799. PubMed ID: 29885481
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.
    Fallon MJ; Heck JN
    J Oncol Pharm Pract; 2015 Oct; 21(5):388-92. PubMed ID: 25005569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stevens-Johnson syndrome associated with radiation recall dermatitis in a patient treated with immune checkpoint inhibitor.
    Horii M; Kobayashi T; Maeda S; Takehara K; Matsushita T
    J Dermatol; 2019 Nov; 46(11):e434-e436. PubMed ID: 31342541
    [No Abstract]   [Full Text] [Related]  

  • 38. Toxic epidermal necrolysis accompanied by several immune-related adverse events developed after discontinuation of nivolumab.
    Watanabe Y; Yamaguchi Y; Takamura N; Takahashi Y; Aihara M
    Eur J Cancer; 2020 May; 131():1-4. PubMed ID: 32248069
    [No Abstract]   [Full Text] [Related]  

  • 39. Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital.
    Yeung CK; Ma SY; Hon C; Peiris M; Chan HH
    Acta Derm Venereol; 2003; 83(3):179-82. PubMed ID: 12816151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.